Pharma major Cipla gets USFDA nod for rare genetic condition treatment drug

Cipla's Icatibant injectable pre-filled syringe in the strength of 30mg/3mL is generic version of Shire's Firazyr, the company said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/32cgH37
via IFTTT